In a Cancer Therapy Advisor article on the state of cancer research, Lisa Coussens, Ph.D., discusses some of the struggles the field has faced since the COVID-19 pandemic. She says: “A lot of young people left the field. Some postdocs decided to abandon an academic postdoc during the pandemic because if they were here on a visa with a limited amount of funding to support their career in the US and the lab was going to be closed for 6 to 9 months, they went home.”

OHSU spinout company Convergent Genomics has developed a urine-based test to diagnose and monitor recurrence and help select therapies for urothelial cancer patients.

A study led by Peter Campbell, M.D., Ph.D., found a smartphone camera can help doctors identify the condition prematurity of retinopathy, which can cause blindness if not treated early.

OHSU doctors say a tiny spot was discovered on a patient's cheek measuring just 0.65 millimeters or 0.025 inches.

Oregon Health and Science University (OHSU) dermatologists have been recognized by the Guinness Book of World Records after dermatologists discovered the smallest skin cancer ever detected.

In an interview with KGW-TV, Sancy Leachman, M.D., Ph.D., discusses the importance of cancer early detection, the latest skin cancer imaging technology, as well as the recent recognition of an OHSU team who detected the world's smallest skin cancer. She says: “It’s the one cancer that you can really see yourself. I think we could cause the melanoma death rates to plummet if all we did was look.”

OHSU is listed as one of two top maternity hospitals in Oregon in a Becker's Hospital Review story.

OHSU pediatric and adult surgeons worked together to save the life of an 8-month-old girl who had a bulge in her abdominal aortic artery, a condition that is normally found in older men. Sheree Shalhub, M.D., says: “It was really a beautiful collaboration, and everyone brought their A game. We all took pieces from our collective experiences from other forms of disease to figure out how we could care for Blakely."

The Lund Report covers Senate Bill 463, which prohibits insurers from requiring prior approval for proton beam therapy and includes a statement from OHSU: “Proton therapy is one of the many radiation therapy technologies that have unique advantages and some distinct disadvantages. OHSU continually assesses new technologies and whether investing in them will ultimately benefit Oregonians. There are no specific plans to offer proton therapy treatment at this time.”

Allison Lindauer, Ph.D., N.P., is interviewed in a KUOW story about social stigma around age-related memory loss or dementia.